Literature DB >> 3528396

In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material.

E L Oleszak, L Manuelidis, E E Manuelidis.   

Abstract

Previous studies indicated that tissue culture cells derived from Creutzfeldt-Jakob disease (CJD) brains possess neoplastic properties. In order to see if CJD brain material could itself transform cells in vitro, BALB/C-3T3 and normal hamster brain monolayer cultures were exposed to whole brain homogenate or synaptosomal-mitochondrial fractions derived from CJD or control brains. Cells were exposed for seven days to CJD or control brain material, washed, and then passaged at weekly intervals. Transformation was evaluated by loss of contact inhibition, replication of cells with absent or low serum content of the medium and significant colony formation in soft agar. Seven parallel experiments were done, and six were viable. All cultures exposed to CJD material containing greater than or equal to 10(4) LD50 infectious units were positive for transformation (five of six studies); the single negative experiment contained only 2 X 10(3) infectious units. Definitive transformation could be observed at 12-16 weeks after application of both mouse and hamster CJD material. BALB/C-3T3 cells exposed to control hamster or mouse brain material were studied for greater than 120 passages in vitro and showed no comparable changes or evidence of spontaneous transformation, i.e. they required serum for replication and produced essentially no colonies in soft agar. Similarly, a normal adult hamster brain culture exposed to control brain material showed no evidence of transformation, whereas the identically passaged normal brain culture exposed to CJD material not only became a permanent line, able to grow in soft agar, but also was capable of producing tumors in nude mice. Thus CJD transformation was not confined to special potentials of "permanent" BALB/C-3T3 cells. These experiments suggest that a genomic alteration can be effected by CJD material.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528396     DOI: 10.1097/00005072-198609000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Scrapie-associated prion protein accumulates in astrocytes during scrapie infection.

Authors:  J F Diedrich; P E Bendheim; Y S Kim; R I Carp; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

2.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Altered intermediate filament expression in human neuroblastoma cells transformed by a growth-promoting agent derived from schizophrenic CSF.

Authors:  S Shirabe; W H Fang; J P Schwartz
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

4.  Astrocyte gene expression in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; D M Tesin; T Sklaviadis; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.

Authors:  E E Manuelidis; W W Fritch; J H Kim; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Growth factor production by Creutzfeldt-Jakob disease cell lines.

Authors:  E L Oleszak; G Murdoch; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD.

Authors:  Laura Manuelidis
Journal:  J Neurovirol       Date:  2010-12-07       Impact factor: 2.643

8.  Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.

Authors:  Larisa Cervenakova; Sergey Akimov; Irina Vasilyeva; Oksana Yakovleva; Carroll McKenzie; Juraj Cervenak; Pedro Piccardo; David M Asher
Journal:  Transfusion       Date:  2011-02-08       Impact factor: 3.157

9.  Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.

Authors:  A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; E E Manuelidis
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.